Blog
RSS FeedPosted by Michael Wonder on 29 Jun 2023
Commonwealth loses appeal in clopidogrel PBS damages undertaking case: important lessons for patentees and generics alike
27 June 2023 - Commonwealth claims on the damages undertaking remain a live issue for patentees and generics to consider. ...
Posted by Michael Wonder on 16 Aug 2020
Direct or indirect comparison: reliance on innovative drug data key to engaging data protection
15 August 2020 - The Federal Court recently issued its decision in Natco v Canada (Minister of Health), 2020 FC 788, ...
Posted by Michael Wonder on 24 Sep 2019
Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices
23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...
Posted by Michael Wonder on 09 Sep 2019
Subscription model for antibiotic development
6 September 2019 - An unlikely answer to the global crisis in antibiotic resistance. ...
Posted by Michael Wonder on 21 Aug 2019
Chinese stealing health and medical research data: report
21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...
Posted by Michael Wonder on 19 Oct 2018
Competition watchdog’s appeal over Pfizer ruling dismissed
19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...
Posted by Michael Wonder on 01 Oct 2018
Age-related macular degeneration: treatment at what cost?
29 September 2018 - An estimated 8·4 million people worldwide have moderate to severe vision loss caused by age-related macular degeneration. ...
Posted by Michael Wonder on 23 Sep 2018
NHS wins legal battle against drugs giants over saving millions with cheaper medicine
21 September 2018 - The NHS has won a landmark battle against drug giants paving the way for the health ...
Posted by Michael Wonder on 19 Sep 2018
Truvada ruling could allow cheap HIV prevention in the UK
19 September 2018 - Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk ...
Posted by Michael Wonder on 17 Jun 2018
Drug patents could be Canada's special weapon in U.S. trade dispute
16 June 2018 - Taking an 'asymmetrical' approach and targeting U.S. intellectual property has worked in the past, experts say. ...
Posted by Michael Wonder on 26 Feb 2018
NHS could claw back £502m if Lyrica ruling upheld, study finds
26 February 2018 - The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin ...
Posted by Michael Wonder on 02 Sep 2017
Commonwealth of Australia v Sanofi: hearing of Commonwealth's claim commences in Federal Court of Australia
31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...
Posted by Michael Wonder on 03 Jul 2017
Supreme Court hands patent win to pharmaceutical companies
30 June 2017 - Canada’s Supreme Court on Friday struck down rules making it easy for generic drug firms to ...
Posted by Michael Wonder on 04 Apr 2017
Brenzys lists on the Australian PBS and Pfizer denied discovery of documents to establish grounds for patent infringement
4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...
Posted by Michael Wonder on 29 Mar 2017
$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits
29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...